Company / Return on Equity (ROE)
GT Biopharma, Inc. Return on Equity (ROE) History
FY2017-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
3.9%
FY2017
5-year range
3.9% / 3.9%
FY2017-FY2017
Trend
-
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
3.9% in FY2017.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2020 | - | - |
| FY2017 | 3.9% | - |
| FY2016 | - | - |
| FY2015 | - | - |
| FY2014 | - | - |
| FY2013 | - | - |
| FY2012 | - | - |
| FY2011 | - | - |
As of FY2017 · SEC 10-K · Updated Jun 24, 2026